• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

The Weekly Roundup: August 11-15

Key Takeaways

  • Nektar's Rezpegaldesleukin shows promise in treating autoimmune disorders, including alopecia and lupus, potentially revolutionizing therapy approaches.
  • Guselkumab demonstrates significant long-term benefits for plaque psoriasis, improving quality of life and reducing stigmatization.
SHOW MORE

In case you missed it, this week we had news about the first annual GPP Awareness Day, a warning from the FDA on whipped sunscreens, the accuracy of vitiligo video content on TikTok, and more.

dermatology times weekly roundup graphic

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Highlighting Recent Advancements During Psoriasis Action Month

Explore the latest advancements in psoriasis treatment, including pediatric care and innovative therapies, during Psoriasis Action Month. Stay informed!

50th Annual Society for Pediatric Dermatology Meeting: Full Conference Recap

Explore key insights and highlights from SPD 2025, focusing on pediatric dermatology advancements, innovative treatments, and expert reflections from the conference.

How Nektar's Rezpegaldesleukin Could Redefine Treatment for Autoimmune Disorders

Nektar Therapeutics and Jonathan Zalevsky, PhD, are exploring REZPEG's potential in treating alopecia, atopic dermatitis, lupus, and diabetes, aiming for groundbreaking autoimmune therapies.

Q&A: How Maria Urbani, MD’s Personal Experience with Rosacea Inspired a New and Inclusive Skin Care Line

IKI Skin Care by Maria Urbani, MD offers effective solutions for rosacea and sensitive skin through science-backed, minimalist formulations.

It’s Time to Treat Moderate Psoriasis Seriously

Explore the evolving landscape of moderate psoriasis treatment, emphasizing patient-centered care and innovative therapies for improved quality of life.

Low BSA Psoriasis Can Carry High Disease Burden

New insights reveal that those with low BSA involvement often face significant disease burdens, challenging traditional treatment criteria.

Guselkumab Improves QoL in Plaque Psoriasis Patients, According to Long-Term G-EPOSS Study Results

New 76-week data reveals guselkumab's significant benefits for plaque psoriasis, enhancing clinical outcomes, improving quality of life, and reducing stigmatization.

HS Summit Spotlights Gaps in Diagnosis and Care

Steven Daveluy, MD, highlighted lack of awareness and early misdiagnosis as major barriers to effective HS care.

Journal Digest: August 13, 2025

This review of the latest dermatologic studies includes findings on cybersecurity practices in dermatology, compression therapy for cellulitis, melanoma overdiagnosis, and more.

Practical Guidance for Utilizing Dermatology Times Event Systemic Therapies in Atopic Dermatitis

Explore personalized systemic therapies for atopic dermatitis, addressing patient needs, treatment options, and enhancing adherence for better outcomes.

Vitiligo's Deep Impact on Life Choices

Vitiligo significantly influences patients' quality of life, affecting major life decisions and increasing perceived stigma.

Pembrolizumab Becomes First Approved Perioperative Immunotherapy for Resectable HNSCC in Canada

Merck's pembrolizumab gains Health Canada approval for innovative perioperative treatment of advanced head and neck squamous cell carcinoma, enhancing patient outcomes.

The Most Popular Vitiligo Content on TikTok Lacks Medical Accuracy

TikTok's vitiligo content reveals a critical need for reliable clinical information from HCPs, highlighting the gap between engagement and accuracy in health education.

Q&A: Celebrating the First Annual GPP Awareness Day

Shannon C. Trotter, DO, FAOCD, FAAD, and patient Janene Tirado, highlight GPP Awareness Day and the urgent need for recognition and understanding of generalized pustular psoriasis.

3 Cases, 3 Triumphs: Rethinking AD Management

Explore innovative nonsteroidal treatments for atopic dermatitis, as experts discuss personalized care strategies to enhance patient quality of life.

Evaluating Product Safety Profiles in Eczema Care: A Closer Look at the NEA Seal of Acceptance

Discover how the NEA Seal of Acceptance helps clinicians recommend safe eczema products, ensuring quality and sensitivity for patients with atopic dermatitis.

FDA Targets Whipped Sunscreens in Warning Letters

The FDA warned Supergoop and Vacation Inc. for marketing unapproved mousse sunscreens.

Living Evidence: Long-Term Benefits of HS Clinical Trial Enrollment

Andrade's inspiring journey highlights the challenges of HS and the transformative impact of clinical trials.

Q&A: Bringing Dermatologist Expertise to Everyday Sun Care with SunSolve MD and Revieve

Irina Mazur spoke to Dermatology Times about the latest partnership, which aims to bridge the gap between clinical advice and patient behavior through personalized sun protection guidance.

Biologic Therapy Shows Promise for Tough Acne

Explore innovative acne therapies, including bimekizumab, offering hope for treatment-resistant acne conglobata and improved patient outcomes.

Data Innovation May Accelerate CSU Research

Explore how synthetic data revolutionizes CSU research, enabling smaller sample sizes and enhancing trial efficiency and inclusivity.

Virtual Therapy Shows Promise for Dermatological Body-Focused Repetitive Behaviors

Discover how internet-based therapy effectively treats dermatological BFRBs like trichotillomania and dermatillomania, enhancing patient outcomes and accessibility.

Uniting Experts and Advocates to Advance HS Care

A recent HS Summit hosted by UCB brought together clinicians and patient advocates to strengthen research and awareness efforts.

New Insights On the Link Between Comedogenic Cosmetics and Acne

The latest study reveals the link between cosmetic use and acne, highlighting the risks of comedogenic ingredients in moisturizers, facial cleansers, and powders.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.